Acadia Pharmaceuticals Inc

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,502,617

Value ($000)

40,135

Weight

0.0%

2019 Q4 - 2025 Q4 (10 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	40,135	0.0%	1,502,617	12/31/2025
2025 Q3	11/13/2025	35,187	0.0%	1,648,864	9/30/2025
2025 Q2	8/13/2025	7,257	0.0%	336,438	6/30/2025
2023 Q3	11/14/2023	1,144	0.0%	54,901	9/30/2023
2022 Q2	8/15/2022	861	0.0%	61,099	6/30/2022
2020 Q4	2/12/2021	326	0.0%	6,100	12/31/2020
2020 Q3	11/12/2020	5,930	0.0%	143,761	9/30/2020
2020 Q2	8/12/2020	13,869	0.0%	286,134	6/30/2020
2020 Q1	5/15/2020	1,394	0.0%	33,000	3/31/2020
2019 Q4	2/13/2020	27,689	0.1%	647,248	12/31/2019